General Information of Drug (ID: DMVWEN3)

Drug Name
Sulfamic acid 7-sulfamoyloxy-heptyl ester Drug Info
Synonyms
Hepsulfam; 1,7-Heptanediol disulfamate; 96892-57-8; Sulfamic acid, 1,7-heptanediyl ester; 7-sulfamoyloxyheptyl sulfamate; heptane-1,7-diyl disulfamate; NSC 329680; Sulfamic acid 7-sulfamoyloxy-heptyl ester; UNII-971DU2GQ51; CHEMBL182440; GOJJWDOZNKBUSR-UHFFFAOYSA-N; 971DU2GQ51; sulfamic acid 1,7-heptanediyl ester; NSC329680; NSC-329680; AC1L2P3I; AC1Q6YA4; 1,7-Heptanediol bissulfamate; SCHEMBL5409150; C7H18N2O6S2; CTK8D8639; DTXSID90242619; ZINC1574758; HY-U00095; BDBM50154471; CS-7131; SULFAMIC ACID,7-HEPTANEDIYL ESTER
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
100606
CAS Number
CAS 96892-57-8
TTD Drug ID
DMVWEN3

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Carbonic anhydrase I (CA-I) TTHQPL7 CAH1_HUMAN Inhibitor [1]
Carbonic anhydrase II (CA-II) TTANPDJ CAH2_HUMAN Inhibitor [1]
Carbonic anhydrase IX (CA-IX) TT2LVK8 CAH9_HUMAN Inhibitor [1]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Carbonic anhydrase I (CA-I) DTT CA1 5.564 11.952 6.146 7.235
Carbonic anhydrase II (CA-II) DTT CA2 8.796 10.933 9.395 9.819
Carbonic anhydrase IX (CA-IX) DTT CA9 5.04 6.156 4.609 6.756
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Carbonic anhydrase I (CA-I) DTT CA1 5.23E-14 -0.11 -0.41
Carbonic anhydrase II (CA-II) DTT CA2 7.95E-08 0.52 0.33
Carbonic anhydrase IX (CA-IX) DTT CA9 1.12E-10 -0.03 -0.09
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates. Bioorg Med Chem Lett. 2005 Feb 1;15(3):579-84.